metabolism, affecting both methylmalonyl-CoA a n d homocysteine (Hcys) degradation. W e h a v e recently diagnosed 2 patients with this disorder. AH. a 3 w e e k old male, presented with lethargy, decreased oral intake, dehydration a n d pancytopenia. There had been a preceding upper respiratory infection. Parents w e r e first-cousin Saudi Arabians. V M , aHispanic female, presented a t 1 9 d a y s o f life with lethargy. hyptonicity, dehydration, cough, decreased oral intake, significant thrombocytopenia, and mild pancytopenia. absence o f acute metabolic derangement (acidosis, hyperammonemia, hypoglycemia, ketosis) combined with features (lethargy, obtundation) suggesting sepsis; a n d 2) significantly increased C S F Hcys m a y be the underlying cause o f altered neurologic status in these patients.
Evaluatron and management of urea cycle dlsorders usmg stable lsotope mfuslons Scaal~a'. W 0' Bnen'. Judv Rosenberae?'. P Reedsv and B Lee' 'Depamnent of Molecular and Human Genetics. 'Department of Pedlatncs, and 'Chlldrens Nutr~tlon Research Center, Baylor College of Medlclne, Houston. TX Dlagnoslng panlal urea cycle deficlencles based on cllnlcal and laboratory data 1s d~fficult and there 1s often poor conelatlon between genotype, m vlbo enzyme actlvlty. and phenoryplc expression We have used stable lsotope mfuslons to measure total body alutamlne and urea flux for the evaluation of patlents wlth urea cycle dlsorders ~e h & e prev~ously determlned the rate of total body urea producnon by measurlng blood "C-urea ~sotoplc enrichment durlng an lnfuslon wlth the stable lsotope "C-urea. and the propon~onal conmbut~on ofperlpheral nlbogen to urea synthesis by measurlng the lncorporatlon of '% from "N glutamlne Into '% urea The ratlo of the lsotoplc ennchments of '% urea1"~-glutamlne (I%-UIG) allowed us to dlstlngulsh carrlers for om~thlne banscarbamylase delic~ency (OTCD) both from them affected offspring and from normal control sub~ects (Lee el al . subnuned) Collechvely these data suggest that the flux from '% glutamlne to '%urea IS a sensltlve measure ofurea cycle achvlty and 1s capable of dlfferentlatmg female camers for OTCD from normal conbols We have now applled thls method to the 1) dlagnosls of asymptomahc at nsk parl~al OTCD females. 2) Ilbatlon of dletary protem tolerance for managmg a severe OTCD male pahent, and 3) comparlson of differences In the b~oava~labll~ty of enteral vs systemlc sources of nlbogen for total body urea product~on By determmlng the "7-UIG ratlo In 5 at-nsk females m two OTCD slbshlps m whch mutahons were not found In the Index case, we were able to measure normal and abnormal ureaproduct~on and determine carner status In the second case, we determlned total body glutamlne flux at 1 2 gm~kglday and at 0 8 gmlkglday protem Intake m a 7 month null achv~ty OTCD male to tlbate protem tolerance and gulde dletary therapy In the lhlrd case, we tested the hypothesis that lntestlnally generated ammonla and alanlne are more effectwe lmmed~ate precursors for urea synthes~s than penpherally generated glut-ne and as a consequence lndlvlduals who have a compromised urea cycle act~vlty would metabolue excesslve dietary protem more effecnvely than penpherally generated protein By comparing the transfer of '% fromoral and lnbavenous '%H,CI to urea, we found that mdlv~duals who have pamal urea cycle achvlty metabollze excesslve dtetary proteln more efficiently, underlying the observation that these patlents are pamcularly suscepbble to shess and fasMg In conclusion h s approach may also lead to ~mprovements m the nutnt~onal management of panens wlth urea cycle defects and those who are severely catabol~c d u m g cnhcal rllness 64% and 42% of pregnancies carrying fetuses with isolated LCHAD deficiency or complete TFP deficiency were also associated with premature delivery and birth weight that was small for gestational age, respectively. All pregnancies with heterozygous or wild-type fetal genotypes were uncomplicated. 39% (12131) of the affected children died. Ten with isolated LCHAD deficiency and 2 with complete TFP deficiency. Four of these children had sudden, unexplained death at few months of age and certified initially as SIDS. Autopsy revealed micrw and macro-vesicular hepatic steatosis. Screening for TFP mutations revealed homozygosity for the prevalent (GI 528C, E474Q) mutation in all four children. In five families, there was a history of sudden, unexplained death in a sibling o f unknown genotype. These results document that: I) fetal genotype affects both maternal and fetal outcomes in families with TFP mutations; 2) affected children, if unrecognized and untreated, may suffer sudden death. Myotonlc dystrophy has been shown to be caused by an expansion of a CTG repeat In the 3' unbanslated reglon of the myotomn-protein kinase gene (DMPK). Congemtal myotoruc dystrophy (CDM) 1s the most severe phenotype and is charactmzed by marked hypotoma, and faclal weakness at birth Respuatory dlis also common. lndtvlduals wth CDM tend to have larger numbers of CTG repeats than inmvlduals with the other forms of DM, wth sizes r a n p g from 700 to >2000 repeats; however, chae is conndaable overlap and not all mdlvlduals wlth large repeats have CDM. Most cases of CDM are matemally inherited and the Ilkellhood of h a m g a sffond child affected wth CDM h a been est~mated to be 90-100% dthe expanded allele is passed on. We repon a baby. born afta a nbllng wth CDM, who does not have symptoms of congenital myotomc dystrophy desp~te havlng 1000 CTG repeats.
At delivery the proband was extremely floppy and requued mtubation due to respiratory d~stress He remalned venhlator-dependant and died 40 days later. The pregnancy had been complicated by polyhydrmos Southm blot analysls showed that he had a smear of DMPK CTG repeats ranging m size between 17M) and 2300. The mother had gnp myotoma and a typical myotomc facis. Molecular analysis revealed a repeat size of600. Her lhen 6 year old daughter who had s i p s consistent with childhoodonset DM was found to have 1300 CTG repeats. Prenatal diagnosis was off& for a subsequent pregnancy. Anaiys~s of CVS revealed an sipension of 1000 repeats in the fetus. Sizing was repeated on anuuocytes wlth the same result As an expansion of chis size is w i k n the range found m CDM and as the mother had had a previous affected child, the l~kelihood lhat this fetus would have CDM was considered high The mo(her decided to continue wth the pregnancy and was mduced at 39 weeks gestation after a normal pregnancy The baby had no evidence of CDM The neonatal reflexes were normal and there was no respiratory distress Analysis of DNA from cord blood confumed the reslllts obtained for both CVS and m o c y t e s .
This case dlwates that a fetus with a large CTG expansion in the CDM range, will not necessarily present with CDM despite having had a sibling with CDM Genetics IN M e k i n e
